Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Necrosulfonamide is a novel inhibitor of MLKL.
Description | Necrosulfonamide is a novel inhibitor of MLKL. |
In vivo | Necrosulfonamide attenuates the spinal cord injury via necroptosis inhibition[1] |
Animal Research | Pathologic condition was detected using hematoxylin-eosin staining on injured spinal cord and other major organs. Necroptosis-related factors-RIP1, RIP3, and MLKL-were detected using Western blot. Detections on mitochondrial functions such as adenosine triphosphate generation and activities of superoxide dismutase and caspase-3 were also performed. Finally, ethologic performance was detected using a 21-point open-field locomotion test[1]. |
Synonyms | N-[4-[[(3-甲氧基吡嗪基)氨基]磺酰基]苯基]-3-(5-硝基-2-噻吩基)-2-丙烯酰胺 |
Molecular Weight | 461.47 |
Formula | C18H15N5O6S2 |
CAS No. | 432531-71-0 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 10 mM
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Necrosulfonamide 432531-71-0 MAPK信号通路 MLK Inhibitor inhibitor inhibit